Yayın: Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent
| dc.contributor.author | Aygun, Aysenur | |
| dc.contributor.author | Gülbagca, Fulya | |
| dc.contributor.author | Ozer, Lutfiye Yildiz | |
| dc.contributor.author | Ustaoglu, Buket | |
| dc.contributor.author | Altunoglu, Yasemin Celik | |
| dc.contributor.author | Baloglu, Mehmet Cengiz | |
| dc.contributor.author | Atalar, Mehmet Nuri | |
| dc.contributor.author | Alma, Mehmet Hakkı | |
| dc.contributor.author | Sen, Fatih | |
| dc.date.accessioned | 2026-01-04T13:55:37Z | |
| dc.date.issued | 2020-02-01 | |
| dc.description.abstract | Herein, the biogenic platinum nanoparticles (Pt NPs) were synthesized by using black cumin seed (Nigella sativa L.) extract as a reducing agent. The biogenic platinum nanoparticles synthesized by black cumin seed extract was characterized in detail by Transmission Electron Microscopy (TEM), UV-vis spectrophotometer, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS). According to TEM analysis, Pt nanoparticles have spherical shapes and sizes between 1-6 nm. Moreover, the biogenic Pt NPs was assessed for its cytotoxicity effect on MDA-MB-231 breast and HeLa cervical cancer lines and their antibacterial effect against selected strains of gram-positive and negative bacteria. The cytotoxicity and bacterial tests showed the effectiveness of biogenic Pt nanoparticles. Dose-dependent toxicity effects were shown in the MDA-MB-231 breast and HeLa cervical cancer lines (IC50: 36.86 μg/mL and 19.83 μg/mL, respectively). In addition, Pt NPs showed high zone diameters against gram-positive and gram-negative bacteria at concentrations of 100 and 500 μg/ml. These results contribute to the development of the pharmaceutical industry as a potential antibacterial and anticancer agent. | |
| dc.description.uri | https://doi.org/10.1016/j.jpba.2019.112961 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/31732404 | |
| dc.description.uri | https://dx.doi.org/10.1016/j.jpba.2019.112961 | |
| dc.description.uri | https://hdl.handle.net/20.500.12438/6715 | |
| dc.identifier.doi | 10.1016/j.jpba.2019.112961 | |
| dc.identifier.issn | 0731-7085 | |
| dc.identifier.openaire | doi_dedup___::0fa800cd67e9f540dee21c1b92b5a323 | |
| dc.identifier.orcid | 0000-0002-8547-2589 | |
| dc.identifier.orcid | 0000-0003-3951-3789 | |
| dc.identifier.orcid | 0000-0003-2993-2605 | |
| dc.identifier.orcid | 0000-0001-9929-9556 | |
| dc.identifier.pubmed | 31732404 | |
| dc.identifier.scopus | 2-s2.0-85075540380 | |
| dc.identifier.startpage | 112961 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/37823 | |
| dc.identifier.volume | 179 | |
| dc.identifier.wos | 000508752400022 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Journal of Pharmaceutical and Biomedical Analysis | |
| dc.rights | CLOSED | |
| dc.subject | MDA-MB-231 | |
| dc.subject | Metal Nanoparticles | |
| dc.subject | Uterine Cervical Neoplasms | |
| dc.subject | Breast Neoplasms | |
| dc.subject | Gram-Positive Bacteria | |
| dc.subject | Inhibitory Concentration 50 | |
| dc.subject | Cell Line, Tumor | |
| dc.subject | Gram-Negative Bacteria | |
| dc.subject | Humans | |
| dc.subject | Nigella sativa | |
| dc.subject | Platinum | |
| dc.subject | Dose-Response Relationship, Drug | |
| dc.subject | Plant Extracts | |
| dc.subject | Antineoplastic Agents, Phytogenic | |
| dc.subject | Anti-Bacterial Agents | |
| dc.subject | Antibacterial | |
| dc.subject | Anticancer | |
| dc.subject | Seeds | |
| dc.subject | HeLa Cervical Cancer Lines | |
| dc.subject | Female | |
| dc.subject | Nigella Sativa L. | |
| dc.subject | Biogenic Platinum Nanoparticles | |
| dc.subject | HeLa Cells | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.api.response | {"authors":[{"fullName":"Aysenur, Aygun","name":"Aysenur","surname":"Aygun","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8547-2589"},"provenance":null}},{"fullName":"Fulya, Gülbagca","name":"Fulya","surname":"Gülbagca","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3951-3789"},"provenance":null}},{"fullName":"Lutfiye Yildiz, Ozer","name":"Lutfiye Yildiz","surname":"Ozer","rank":3,"pid":null},{"fullName":"Buket, Ustaoglu","name":"Buket","surname":"Ustaoglu","rank":4,"pid":null},{"fullName":"Yasemin Celik, Altunoglu","name":"Yasemin Celik","surname":"Altunoglu","rank":5,"pid":null},{"fullName":"Mehmet Cengiz, Baloglu","name":"Mehmet Cengiz","surname":"Baloglu","rank":6,"pid":null},{"fullName":"Mehmet Nuri, Atalar","name":"Mehmet Nuri","surname":"Atalar","rank":7,"pid":{"id":{"scheme":"orcid","value":"0000-0003-2993-2605"},"provenance":null}},{"fullName":"Mehmet Hakkı, Alma","name":"Mehmet Hakkı","surname":"Alma","rank":8,"pid":null},{"fullName":"Fatih, Sen","name":"Fatih","surname":"Sen","rank":9,"pid":{"id":{"scheme":"orcid","value":"0000-0001-9929-9556"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"MDA-MB-231"},"provenance":null},{"subject":{"scheme":"keyword","value":"Metal Nanoparticles"},"provenance":null},{"subject":{"scheme":"keyword","value":"Uterine Cervical Neoplasms"},"provenance":null},{"subject":{"scheme":"keyword","value":"Breast Neoplasms"},"provenance":null},{"subject":{"scheme":"FOS","value":"02 engineering and technology"},"provenance":null},{"subject":{"scheme":"keyword","value":"Gram-Positive Bacteria"},"provenance":null},{"subject":{"scheme":"FOS","value":"01 natural sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Inhibitory Concentration 50"},"provenance":null},{"subject":{"scheme":"keyword","value":"Cell Line, Tumor"},"provenance":null},{"subject":{"scheme":"keyword","value":"Gram-Negative Bacteria"},"provenance":null},{"subject":{"scheme":"keyword","value":"Humans"},"provenance":null},{"subject":{"scheme":"keyword","value":"Nigella sativa"},"provenance":null},{"subject":{"scheme":"keyword","value":"Platinum"},"provenance":null},{"subject":{"scheme":"keyword","value":"Dose-Response Relationship, Drug"},"provenance":null},{"subject":{"scheme":"keyword","value":"Plant Extracts"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antineoplastic Agents, Phytogenic"},"provenance":null},{"subject":{"scheme":"keyword","value":"Anti-Bacterial Agents"},"provenance":null},{"subject":{"scheme":"FOS","value":"0104 chemical sciences"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"keyword","value":"Antibacterial"},"provenance":null},{"subject":{"scheme":"keyword","value":"Anticancer"},"provenance":null},{"subject":{"scheme":"keyword","value":"Seeds"},"provenance":null},{"subject":{"scheme":"keyword","value":"HeLa Cervical Cancer Lines"},"provenance":null},{"subject":{"scheme":"keyword","value":"Female"},"provenance":null},{"subject":{"scheme":"keyword","value":"Nigella Sativa L."},"provenance":null},{"subject":{"scheme":"FOS","value":"0210 nano-technology"},"provenance":null},{"subject":{"scheme":"keyword","value":"Biogenic Platinum Nanoparticles"},"provenance":null},{"subject":{"scheme":"keyword","value":"HeLa Cells"},"provenance":null}],"mainTitle":"Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent","subTitle":null,"descriptions":["Herein, the biogenic platinum nanoparticles (Pt NPs) were synthesized by using black cumin seed (Nigella sativa L.) extract as a reducing agent. The biogenic platinum nanoparticles synthesized by black cumin seed extract was characterized in detail by Transmission Electron Microscopy (TEM), UV-vis spectrophotometer, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS). According to TEM analysis, Pt nanoparticles have spherical shapes and sizes between 1-6 nm. Moreover, the biogenic Pt NPs was assessed for its cytotoxicity effect on MDA-MB-231 breast and HeLa cervical cancer lines and their antibacterial effect against selected strains of gram-positive and negative bacteria. The cytotoxicity and bacterial tests showed the effectiveness of biogenic Pt nanoparticles. Dose-dependent toxicity effects were shown in the MDA-MB-231 breast and HeLa cervical cancer lines (IC50: 36.86 μg/mL and 19.83 μg/mL, respectively). In addition, Pt NPs showed high zone diameters against gram-positive and gram-negative bacteria at concentrations of 100 and 500 μg/ml. These results contribute to the development of the pharmaceutical industry as a potential antibacterial and anticancer agent."],"publicationDate":"2020-02-01","publisher":"Elsevier BV","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":["Aygün, Ayşenur","Gülbağca, Fulya","Şen, Fatih"],"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Pharmaceutical and Biomedical Analysis","issnPrinted":"0731-7085","issnOnline":null,"issnLinking":null,"ep":null,"iss":null,"sp":"112961","vol":"179","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::0fa800cd67e9f540dee21c1b92b5a323","originalIds":["S0731708519321375","10.1016/j.jpba.2019.112961","50|doiboost____|0fa800cd67e9f540dee21c1b92b5a323","31732404","2989039999","oai:openaccess.dpu.edu.tr:20.500.12438/6715","50|od______4611::fae14eb6646a21bdb47dcc26b249d2f7"],"pids":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"},{"scheme":"pmid","value":"31732404"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":151,"influence":6.0209584e-9,"popularity":1.1248481e-7,"impulse":100,"citationClass":"C3","influenceClass":"C4","impulseClass":"C3","popularityClass":"C3"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"license":"Elsevier TDM","type":"Article","urls":["https://doi.org/10.1016/j.jpba.2019.112961"],"publicationDate":"2020-02-01","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"31732404"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/31732404"],"publicationDate":"2020-11-12","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"2989039999"},{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://dx.doi.org/10.1016/j.jpba.2019.112961"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.jpba.2019.112961"}],"type":"Article","urls":["https://hdl.handle.net/20.500.12438/6715"],"publicationDate":"2019-01-01","refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false} | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
